Room: White Plains Ballroom

Presenting Wednesday-Friday

Poster Presenters noted with * are Student Fellows.

Agency for Science, Technology and Research (A*STAR)
1.         DAPPLeD: Data Analytics Platform for Phenotypic Lead Discovery; Presented by Judice K.

2.         Liver Spheroids as a Model to Determine Hepatic Safety and Metabolism; Presented by Linda A.

3.         Evaluation and Characterization of Human Hepatocyte Donors to Be Used for ADME and Safety in Liver Spheroid Model; Presented by Bhavik C.

Biogelx Ltd.
4.         Designer Hydrogels for 3D Cell Culture and Bioprinting; Presented by Elia L.

5.         Mouse Models of Nonalcoholic Steatohepatitis (NASH) and NASH-Derived Hepatocellular Carcinoma in Preclinical Drug Development; Presented by Pierre M.

6.         The Antioxidant N-Acetyl-L-Cysteine (NAC) as a Pharmacological Candidate for Age-Related Hearing Loss; Presented by Sylvie C.

Crown Bioscience, Inc.
7.         Generation of Human Immune Checkpoint Double Knock-In Mice (dKI HuGEMM) for Preclinical Efficacy Assessment of Combinatorial Therapeutic Antibodies; Presented by Sebastian D.

Cyprotex Discovery
8.         A Comprehensive Approach Using In Vitro Assays to Detect and Identify Mechanism of Mitochondrial Toxicity; Presented by Julie E.

9.         Anti-Tumor Efficacy of Anti-GITR in Preclinical hGITR Model; Presented by Kader T.

Gilead Sciences
10.       SEND Systems Approach; Presented by Nidhi N.

Glycotope GmbH
11.       A Highly Tumor-Specific T Cell Engaging Bispecific Antibody Targeting TA-MUC1 Induces Strong T Cell Infiltration in 3D MCF-7 Tumor Spheroids; Presented by Timo L.

Hungarian Academy of Sciences
12.       Functional Characterization of Human Neural Progenitor Cells Differentiated from Pluripotent Stem Cells; Presented by Agota A.

Hybrigenics Services SAS
13.       Phenotypic Screening Combined to Target Deconvolution Identifies Novel Modulators of Beta-Cell Regeneration; Presented by Marie-Edith G.

Jesus Uson Minimally Invasive Surgery Centre (JUMISC)
14.       Feasibility Study Combined with Diagnostic Techniques of Colorectal Cancer Such as Endoscopy, Solid Biopsies and Liquid Biopsies in a Murine Model; Presented by Jorge B.*

Jesus Uson Minimally Invasive Surgery Centre (JUMISC)
15.       Pre-Clinical Stage to Develop a Multimodal Highly-Sensitive Photonics Endoscope for Improved In-Vivo Colon Cancer Diagnosis and Clinical Decision Support; Presented by Jose G.*

Ludwig-Maximilians-University of Munich
16.       Pathway Sensor-Based Functional Genomics Screening Identifies Modulators of Neuronal Activity; Presented by Alexander H.

Mahidol University
17.       Development of Interpretable Computational Models for Breast Cancer Drug Discovery; Presented by Naravut S.*

MicroMatrices Associates Ltd.
18.       An iPSC Platform for Brain Tumour Drug Development and Personalised Medicine; Presented by Simon P.

MI-mAbs (Protisvalor)
19.       CD3ε Humanized Mice: A New Tool to Validate Your Bi-Specific T Cell Engager Molecule; Presented by Agnes M.

20.       Simultaneous Measurement of Contractility, Electrophysiology, and Troponin I Secretion to Determine Cardiotoxicity in hiPSC-Derived Cardiomyocytes; Presented by Alexandre F.

21.       Transcriptomics Data Integration: Promoting Target Discovery in Immuno-Oncology; Presented by Natalie R.

Oxford NanoImaging Ltd.
22.       The Power of Single-Molecule Fluorescent Techniques in the Development of Improved Drug Discovery and Target Validation Platforms; Presented by Mariya G.

ProQinase GmbH
23.       New Spontaneous and Carcinogen Induced Mouse Derived Isograft (MDI) Tumor Models for Drug Development of Novel Immune Therapeutic Approaches; Presented by Bettina S.

TNO - The Netherlands Organization for Applied Scientific Research
24.       Organ Cross-Talk in the Development of Obesity-Related Diseases; Presented by Ivana B.

TNO - The Netherlands Organization for Applied Scientific Research
25.       Development of a Diet-Induced Disease-Mimicking In Vitro Model of Non-Alcoholic Steatohepatitis (NASH)/ Fibrosis; Presented by Elsbet P.

TNO - The Netherlands Organization for Applied Scientific Research
26.       GUT ON-A-CHIP: Intestinal Barrier Model for Studying Host Microbe-Immune Responses; Presented by Evita V.

TNO - The Netherlands Organization for Applied Scientific Research
27.       Novel Translational Approaches for Preclinical Research in the Area of Non-Alcoholic Fatty Liver Disease; Presented by Lars V.

University of Illinois at Chicago
28.       Target Discovery of Natural Product Inspired Phyllanthusmins for Treatment of High Grade Serous Ovarian Cancer; Presented by Alexandria Y.*

University of Lisbon
29.       Ablation of TREM-2 Reveals a Resident Macrophage Population Impairing Tissue Repair Responses to Liver Damage; Presented by Ines C.*

Tempo Bioscience, Inc.
30.       Human iPSC Models for Drug Discovery; Presented by Angela H.

São Paulo State University - UNESP
31.       GA-Hecate Antiviral Properties on HCV Whole Cycle Represent a New Antiviral Class and Open the Door for the Development of Broad Spectrum Antivirals; Presented by Paulo S.*